▁Introduction 10.375
: 6.515625
<0x0A> 3.990234375
P 4.66015625
rem 4.5546875
ature 3.0546875
▁men 6.7734375
op 0.1285400390625
ause 0.00881195068359375
▁pos 7.6796875
es 0.01065826416015625
▁unique 5.2109375
▁challeng 1.1259765625
es 0.0003056526184082031
▁for 0.97900390625
▁middle 6.625
- 0.102294921875
aged 0.061798095703125
▁women 0.61279296875
, 1.5048828125
▁particularly 2.953125
▁when 3.0625
▁accompanied 5.15234375
▁by 0.040313720703125
▁ob 5.46484375
es 0.0589599609375
ity 0.00011801719665527344
▁and 1.4658203125
▁a 2.82421875
▁pre 5.28125
dis 0.46044921875
position 0.01377105712890625
▁to 0.371337890625
▁breast 3.248046875
▁cancer 0.08929443359375
. 0.200927734375
▁Cho 10.15625
osing 0.57568359375
▁the 1.3271484375
▁appropriate 2.794921875
▁treatment 1.798828125
▁for 1.419921875
▁man 8.4921875
aging 0.0256805419921875
▁its 9.6875
▁sympt 0.71240234375
oms 0.0087890625
▁becomes 5.33984375
▁cru 3.82421875
cial 0.015655517578125
. 1.08203125
▁This 2.630859375
▁ess 7.45703125
ay 0.0037059783935546875
▁a 2.353515625
ims 0.0010347366333007812
▁to 0.0538330078125
▁assess 4.3515625
▁the 0.34375
▁potential 3.955078125
▁ris 2.89453125
ks 0.00044274330139160156
▁and 0.322509765625
▁benefits 0.1697998046875
▁of 0.14501953125
▁using 3.794921875
▁Met 9.6796875
op 3.384765625
rol 0.0030765533447265625
ol 0.0014476776123046875
▁compared 6.0234375
▁to 0.416748046875
▁Nor 5.80859375
vas 0.73193359375
c 0.0018243789672851562
▁and 2.57421875
▁highlight 8.28125
▁how 4.59375
▁di 7.2734375
et 1.734375
▁and 1.2021484375
▁sm 6.61328125
oking 0.0025653839111328125
▁should 4.421875
▁be 0.30029296875
▁considered 0.68798828125
▁in 1.4052734375
▁the 1.134765625
▁treatment 1.7177734375
▁plan 2.919921875
▁for 2.046875
▁this 2.3359375
▁specific 4.65625
▁population 2.0625
. 0.1900634765625
<0x0A> 0.356201171875
R 4.62109375
isk 1.2060546875
- 3.484375
Ben 1.4130859375
ef 0.00012576580047607422
it 0.0241851806640625
▁Analysis 1.7041015625
▁of 1.560546875
▁Met 0.408935546875
op 0.024169921875
rol 0.0008378028869628906
ol 0.0003592967987060547
▁and 2.591796875
▁Nor 0.12139892578125
vas 0.0035648345947265625
c 0.0007343292236328125
: 3.40234375
<0x0A> 0.2939453125
Met 1.2763671875
op 0.006580352783203125
rol 0.0009069442749023438
ol 0.0002677440643310547
, 3.125
▁a 1.1962890625
▁beta 0.826171875
- 0.3828125
block 0.22998046875
er 0.2352294921875
, 0.36474609375
▁and 4.1953125
▁Nor 0.302490234375
vas 0.0016641616821289062
c 0.0005121231079101562
, 0.125732421875
▁a 0.8623046875
▁calci 0.0947265625
um 4.017353057861328e-05
▁channel 0.2491455078125
▁block 0.07177734375
er 0.00627899169921875
, 0.119384765625
▁possess 6.80078125
▁distinct 2.62890625
▁attributes 5.796875
▁that 1.2255859375
▁must 5.73828125
▁be 0.01250457763671875
▁considered 0.70361328125
▁in 1.0322265625
▁this 4.4375
▁context 3.357421875
. 0.1534423828125
▁Met 0.67529296875
op 0.01432037353515625
rol 0.0019025802612304688
ol 0.00010991096496582031
▁primarily 7.34375
▁targets 2.26171875
▁the 0.438232421875
▁card 2.833984375
i 1.443359375
ov 0.0116424560546875
asc 0.0017442703247070312
ular 6.568431854248047e-05
▁system 0.09881591796875
▁and 1.978515625
▁man 8.0390625
ages 0.02679443359375
▁hy 3.01953125
pert 0.0021533966064453125
ension 0.01520538330078125
, 1.1298828125
▁while 1.8271484375
▁Nor 0.06146240234375
vas 0.002254486083984375
c 0.00024044513702392578
▁focus 3.34765625
es 0.0004887580871582031
▁on 0.181884765625
▁relax 6.484375
ing 0.0802001953125
▁blood 2.439453125
▁vessels 0.09765625
▁and 1.052734375
▁impro 2.619140625
ving 0.02288818359375
▁blood 0.85986328125
▁flow 0.2161865234375
. 0.423095703125
<0x0A> 2.291015625
Ben 5.16015625
ef 0.005855560302734375
its 0.254150390625
▁of 0.3857421875
▁using 3.927734375
▁Met 0.1231689453125
op 0.01160430908203125
rol 0.0005211830139160156
ol 6.914138793945312e-05
: 1.0224609375
<0x0A> 0.050628662109375
1 4.5546875
. 0.166748046875
▁Card 5.01953125
i 0.41845703125
ov 0.0024242401123046875
asc 0.0016775131225585938
ular 0.00010514259338378906
▁benefits 1.87890625
: 0.7587890625
▁Met 0.9580078125
op 0.004802703857421875
rol 0.0011072158813476562
ol 7.748603820800781e-05
▁effectively 4.9609375
▁addresses 5.43359375
▁the 1.650390625
▁increased 5.24609375
▁risk 1.3984375
▁of 0.11700439453125
▁card 1.5068359375
i 0.10302734375
ov 0.00043582916259765625
asc 0.00018298625946044922
ular 1.3589859008789062e-05
▁issues 3.61328125
▁in 1.5029296875
▁middle 1.7568359375
- 0.05877685546875
aged 0.029449462890625
▁women 0.10565185546875
▁by 3.58984375
▁reducing 1.7001953125
▁heart 3.3984375
▁rate 0.26220703125
▁and 0.72607421875
▁blood 0.58642578125
▁pressure 0.017913818359375
. 0.59130859375
<0x0A> 1.2978515625
2 0.08563232421875
. 0.0017156600952148438
▁Sym 5.16796875
pt 0.021331787109375
om 0.18603515625
▁management 1.7470703125
: 0.11004638671875
▁Met 0.546875
op 0.0031223297119140625
rol 0.0006780624389648438
ol 6.80685043334961e-05
▁may 3.404296875
▁help 2.013671875
▁alle 1.22265625
vi 0.00024771690368652344
ate 0.0006728172302246094
▁some 3.154296875
▁of 0.2113037109375
▁the 0.01300811767578125
▁sympt 1.1962890625
oms 0.00339508056640625
▁associated 1.2490234375
▁with 0.0010690689086914062
▁prem 1.728515625
ature 0.0023326873779296875
▁men 0.045989990234375
op 0.0024509429931640625
ause 0.0028438568115234375
, 0.45654296875
▁such 0.56640625
▁as 0.00151824951171875
▁hot 0.88916015625
▁flash 0.2333984375
es 0.0020389556884765625
▁and 0.966796875
▁night 1.4052734375
▁swe 0.00307464599609375
ats 0.00980377197265625
, 1.4013671875
▁by 1.076171875
▁reg 2.865234375
ulating 0.0012845993041992188
▁the 1.1787109375
▁autonom 3.083984375
ic 0.0382080078125
▁nerv 0.062225341796875
ous 7.081031799316406e-05
▁system 0.0053253173828125
. 0.341552734375
<0x0A> 0.12188720703125
R 3.046875
is 0.331298828125
ks 0.00010895729064941406
▁of 0.33642578125
▁using 0.2313232421875
▁Met 0.0186614990234375
op 0.003223419189453125
rol 0.0003750324249267578
ol 3.647804260253906e-05
: 0.072265625
<0x0A> 0.006427764892578125
1 0.099609375
. 0.0014209747314453125
▁Pot 3.537109375
ential 0.055450439453125
▁breast 6.7109375
▁cancer 0.0467529296875
▁ris 0.8759765625
ks 6.4849853515625e-05
: 0.06341552734375
▁Some 4.45703125
▁studies 0.8740234375
▁have 0.322021484375
▁suggested 1.2158203125
▁that 0.361572265625
▁beta 4.69140625
- 0.04705810546875
block 0.01505279541015625
ers 0.051666259765625
, 1.775390625
▁like 2.416015625
▁Met 0.15478515625
op 0.006900787353515625
rol 0.0004558563232421875
ol 4.875659942626953e-05
, 0.0399169921875
▁may 0.444091796875
▁increase 0.34912109375
▁the 0.2076416015625
▁risk 0.085205078125
▁of 0.0411376953125
▁breast 0.445068359375
▁cancer 0.007354736328125
. 1.328125
▁However 1.0244140625
, 0.0008172988891601562
▁the 2.1171875
▁correlation 6.19140625
▁is 1.44921875
▁not 0.91845703125
▁well 4.75390625
- 0.95849609375
est 0.48974609375
ab 0.00045108795166015625
lished 0.0006928443908691406
▁and 1.1689453125
▁requires 4.35546875
▁further 0.252197265625
▁research 1.1083984375
. 0.160888671875
<0x0A> 0.1168212890625
2 0.043914794921875
. 0.0006275177001953125
▁Limited 8.6796875
▁sympt 8.578125
om 0.006946563720703125
▁relief 0.92578125
: 0.07196044921875
▁Met 1.14453125
op 0.002216339111328125
rol 0.000476837158203125
ol 3.8743019104003906e-05
' 3.5390625
s 0.0003170967102050781
▁effect 2.236328125
iveness 0.0931396484375
▁in 1.234375
▁man 2.705078125
aging 3.552436828613281e-05
▁non 7.81640625
- 0.2152099609375
card 0.673828125
i 0.23486328125
ov 0.00594329833984375
asc 0.00020813941955566406
ular 1.621246337890625e-05
▁sympt 0.29052734375
oms 0.00017213821411132812
▁of 2.93359375
▁men 1.9306640625
op 0.0012073516845703125
ause 0.0280303955078125
, 2.271484375
▁such 0.1298828125
▁as 0.0011777877807617188
▁v 3.98828125
ag 0.017120361328125
inal 0.005523681640625
▁dry 0.054107666015625
ness 0.004085540771484375
▁or 2.66015625
▁m 3.751953125
ood 0.01367950439453125
▁sw 0.366943359375
ings 7.867813110351562e-06
, 0.03656005859375
▁may 1.16015625
▁be 0.79833984375
▁limited 0.4609375
▁compared 2.498046875
▁to 0.061004638671875
▁other 0.8271484375
▁treat 1.3955078125
ments 2.193450927734375e-05
. 0.50341796875
<0x0A> 0.11138916015625
Ben 2.390625
ef 5.733966827392578e-05
its 0.0029087066650390625
▁of 0.039306640625
▁using 0.1729736328125
▁Nor 0.08123779296875
vas 0.002033233642578125
c 0.0002970695495605469
: 0.0279083251953125
<0x0A> 0.0078125
1 0.07403564453125
. 0.0011959075927734375
▁Im 4.68359375
pro 0.0299072265625
ved 0.1180419921875
▁blood 0.193115234375
▁circul 3.064453125
ation 0.0008192062377929688
: 0.06134033203125
▁Nor 0.1624755859375
vas 0.0008368492126464844
c 0.00017201900482177734
' 2.671875
s 0.0004639625549316406
▁mechanism 4.6171875
▁of 0.028289794921875
▁relax 8.5859375
ing 0.12005615234375
▁blood 0.19091796875
▁vessels 0.0089874267578125
▁may 1.8310546875
▁provide 2.99609375
▁relief 2.94921875
▁from 0.533203125
▁certain 4.72265625
▁men 2.265625
op 0.19677734375
aus 0.285888671875
al 2.086162567138672e-05
▁sympt 0.0711669921875
oms 9.644031524658203e-05
, 0.4384765625
▁including 2.423828125
▁mig 5.43359375
ra 0.1370849609375
ines 9.894371032714844e-05
▁and 0.501953125
▁sleep 4.9375
▁dist 1.541015625
urban 0.0008864402770996094
ces 4.363059997558594e-05
, 2.119140625
▁by 0.336669921875
▁en 3.76953125
han 0.08184814453125
cing 1.3113021850585938e-06
▁blood 0.441162109375
▁flow 0.13720703125
. 0.452392578125
<0x0A> 0.0281219482421875
2 0.03485107421875
. 0.0005965232849121094
▁Pot 2.388671875
ential 0.0338134765625
▁breast 1.2685546875
▁cancer 0.00606536865234375
▁protection 5.39453125
: 0.01824951171875
▁Cal 8.4375
ci 0.002025604248046875
um 1.5020370483398438e-05
▁channel 0.034942626953125
▁block 0.01355743408203125
ers 0.00482177734375
▁like 0.6025390625
▁Nor 0.045074462890625
vas 0.0012006759643554688
c 0.0003762245178222656
▁have 1.4248046875
▁shown 3.76953125
▁some 2.796875
▁associations 7.046875
▁with 0.03076171875
▁reduced 0.62890625
▁breast 0.53271484375
▁cancer 0.005706787109375
▁risk 0.1121826171875
, 1.7080078125
▁although 2.0390625
▁more 1.3798828125
▁research 0.1805419921875
▁is 0.052215576171875
▁needed 0.309814453125
▁to 0.376953125
▁establish 2.53515625
▁a 1.9697265625
▁clear 1.9111328125
▁link 1.0859375
. 0.3388671875
<0x0A> 0.03704833984375
R 1.2001953125
is 0.0238037109375
ks 4.887580871582031e-06
▁of 0.03619384765625
▁using 0.01081085205078125
▁Nor 0.02154541015625
vas 0.0006122589111328125
c 0.0002903938293457031
: 0.00814056396484375
<0x0A> 0.00200653076171875
1 0.023773193359375
. 0.0006594657897949219
▁Limited 4.42578125
▁card 4.83984375
i 0.027191162109375
ov 0.00013911724090576172
asc 0.00020945072174072266
ular 1.9431114196777344e-05
▁benefits 0.12493896484375
: 0.01390838623046875
▁Comp 5.12109375
ared 0.0015077590942382812
▁to 0.09967041015625
▁Met 0.2734375
op 0.0028324127197265625
rol 0.0005669593811035156
ol 2.3484230041503906e-05
, 0.01983642578125
▁Nor 0.09228515625
vas 0.0002956390380859375
c 0.0001310110092163086
' 1.5458984375
s 9.763240814208984e-05
▁primary 4.109375
▁focus 3.34765625
▁is 0.1700439453125
▁not 4.6640625
▁on 0.2271728515625
▁man 2.802734375
aging 5.0067901611328125e-05
▁hy 3.142578125
pert 0.00010716915130615234
ension 0.0006618499755859375
. 2.322265625
▁Therefore 2.7109375
, 0.01070404052734375
▁it 0.87255859375
▁may 0.173095703125
▁not 0.1129150390625
▁ade 4.65625
qu 0.00027871131896972656
ately 6.020069122314453e-05
▁address 0.30908203125
▁the 1.05859375
▁card 1.9833984375
i 0.0172271728515625
ov 0.00041174888610839844
asc 0.00012099742889404297
ular 3.314018249511719e-05
▁ris 0.86767578125
ks 5.364418029785156e-06
▁associated 0.30517578125
▁with 0.0006575584411621094
▁ob 8.3125
es 0.008880615234375
ity 1.3232231140136719e-05
▁in 3.376953125
▁women 2.474609375
▁with 2.53125
▁prem 0.39013671875
ature 0.0007166862487792969
▁men 0.0053863525390625
op 0.0004363059997558594
ause 0.0006651878356933594
. 0.1201171875
<0x0A> 0.0164642333984375
2 0.12158203125
. 0.0006737709045410156
▁Side 3.595703125
▁effects 0.06805419921875
: 0.2056884765625
▁Nor 1.1298828125
vas 0.00021278858184814453
c 0.00015079975128173828
' 1.3076171875
s 0.0023059844970703125
▁potential 2.03125
▁side 0.42529296875
▁effects 0.01031494140625
▁may 2.412109375
▁include 0.26416015625
▁ed 5.9609375
ema 0.0040435791015625
, 0.5029296875
▁d 2.02734375
izz 0.0560302734375
iness 7.37905502319336e-05
, 0.088134765625
▁and 0.724609375
▁pal 3.275390625
pit 0.038116455078125
ations 2.8014183044433594e-05
, 1.732421875
▁which 0.38427734375
▁can 1.47265625
▁add 6.49609375
▁additional 2.5234375
▁hard 7.8515625
ships 0.59033203125
▁to 0.65283203125
▁an 2.8359375
▁already 0.02825927734375
▁challeng 1.2265625
ing 0.001071929931640625
▁condition 3.40234375
. 0.1470947265625
<0x0A> 0.04058837890625
In 4.3125
cor 6.01171875
por 0.0004153251647949219
ating 0.09100341796875
▁Diet 1.55859375
▁and 0.277099609375
▁Sm 0.0948486328125
oking 0.0008945465087890625
▁into 0.61669921875
▁the 1.3115234375
▁Tre 0.2484130859375
at 0.0019197463989257812
ment 0.0007624626159667969
▁Plan 0.1246337890625
: 0.52001953125
<0x0A> 0.00836181640625
To 5.02734375
▁optimize 4.05859375
▁the 0.72998046875
▁treatment 1.2265625
▁plan 0.767578125
, 2.0
▁di 2.970703125
et 0.0030117034912109375
▁and 0.225830078125
▁sm 0.03240966796875
oking 0.0002205371856689453
▁hab 2.392578125
its 1.1682510375976562e-05
▁should 0.52099609375
▁be 0.10577392578125
▁taken 2.71484375
▁into 0.00421905517578125
▁account 1.203125
, 3.103515625
▁considering 4.88671875
▁their 1.7607421875
▁potential 0.71142578125
▁impact 1.3212890625
▁on 0.095458984375
▁both 3.275390625
▁medic 5.24609375
ation 0.10223388671875
▁effect 2.642578125
iveness 0.00428009033203125
▁and 0.04351806640625
▁the 3.3828125
▁pro 5.73828125
gression 0.083984375
▁of 0.026947021484375
▁breast 3.74609375
▁cancer 0.043365478515625
: 7.83984375
<0x0A> 0.06329345703125
1 1.4404296875
. 0.01052093505859375
▁Diet 1.8310546875
: 0.93212890625
<0x0A> 2.529296875
a 3.69140625
) 2.03515625
▁Ant 6.5625
io 0.035491943359375
x 0.000652313232421875
id 0.00011146068572998047
ant 0.65673828125
- 1.3740234375
rich 0.11846923828125
▁di 1.046875
et 0.198974609375
: 0.290283203125
▁Enc 7.3359375
ou 0.002086639404296875
rag 0.0938720703125
ing 0.04315185546875
▁a 1.359375
▁di 0.2568359375
et 0.00011968612670898438
▁abund 6.96875
ant 0.0035228729248046875
▁in 0.033966064453125
▁f 1.939453125
ruits 0.0003294944763183594
, 0.58056640625
▁veget 0.046478271484375
ables 0.0008993148803710938
, 0.05792236328125
▁whole 1.3212890625
▁gra 0.03912353515625
ins 0.00421905517578125
, 0.06903076171875
▁and 0.417724609375
▁low 2.396484375
- 0.2137451171875
f 0.06146240234375
at 0.0006237030029296875
▁prote 3.833984375
ins 0.00013303756713867188
▁may 0.87890625
▁enh 4.421875
ance 4.792213439941406e-05
▁general 6.64453125
▁well 0.90771484375
- 0.283447265625
be 0.00016117095947265625
ing 9.775161743164062e-06
▁and 0.4697265625
▁potentially 4.921875
▁reduce 0.755859375
▁the 0.65283203125
▁risk 0.1683349609375
▁of 0.038055419921875
▁cancer 2.73828125
. 0.77197265625
<0x0A> 0.439453125
b 0.2227783203125
) 0.0005140304565429688
▁Ph 5.6015625
y 0.0355224609375
to 0.0268402099609375
estro 0.57666015625
gen 0.0008397102355957031
▁int 3.94140625
ake 0.0018281936645507812
: 0.0285797119140625
▁In 3.1015625
cluding 1.5625
▁food 2.767578125
s 0.140380859375
▁like 2.634765625
▁so 0.54638671875
y 0.00850677490234375
, 1.1767578125
▁fla 2.015625
x 0.0001558065414428711
seed 0.5908203125
, 0.103515625
▁and 0.418212890625
▁leg 5.375
umes 0.0289459228515625
, 2.490234375
▁which 0.58740234375
▁are 1.6015625
▁natural 6.453125
▁sources 0.403564453125
▁of 0.0032787322998046875
▁ph 0.400634765625
y 0.00012493133544921875
to 0.0003535747528076172
est 0.6689453125
rog 0.00728607177734375
ens 9.85860824584961e-05
, 0.197265625
▁may 0.33154296875
▁help 1.240234375
▁manage 4.109375
▁men 1.9365234375
op 0.01111602783203125
aus 0.09649658203125
al 2.6702880859375e-05
▁sympt 0.033721923828125
oms 0.00040793418884277344
. 2.005859375
<0x0A> 0.1705322265625
c 0.6572265625
) 0.000614166259765625
▁We 5.0625
ight 0.0019683837890625
▁management 2.08984375
: 0.07574462890625
▁Prom 4.23046875
oting 0.00922393798828125
▁grad 9.0234375
ual 0.0011491775512695312
▁weight 0.08929443359375
▁loss 0.036773681640625
▁through 2.0390625
▁a 2.015625
▁bal 2.650390625
anced 0.00013267993927001953
▁and 3.755859375
▁cal 4.4296875
orie 0.209228515625
- 0.0147552490234375
control 0.96044921875
led 0.0015554428100585938
▁di 0.03521728515625
et 0.00021779537200927734
▁can 2.140625
▁posit 4.5703125
ively 8.893013000488281e-05
▁impact 0.376220703125
▁card 2.7734375
i 0.01508331298828125
ov 0.025604248046875
asc 4.6253204345703125e-05
ular 8.463859558105469e-06
▁health 0.525390625
▁and 0.71142578125
▁alle 5.20703125
vi 0.0031452178955078125
ate 0.0011777877807617188
▁ob 4.34375
es 0.00997161865234375
ity 0.0013952255249023438
- 0.09722900390625
related 0.142333984375
▁sympt 1.1416015625
oms 0.0006432533264160156
. 0.7587890625
<0x0A> 0.0670166015625
2 0.72705078125
. 0.0011692047119140625
▁Sm 0.0699462890625
oking 0.0023250579833984375
: 0.73388671875
<0x0A> 0.12091064453125
a 0.08837890625
) 0.0019893646240234375
▁Sm 2.00390625
oking 0.12493896484375
▁c 0.9296875
ess 0.01120758056640625
ation 0.00011754035949707031
: 0.1702880859375
▁Qu 2.8671875
itting 0.01169586181640625
▁sm 0.16845703125
oking 0.0010290145874023438
▁is 1.82421875
▁cru 2.771484375
cial 0.0009765625
, 3.87890625
▁as 0.833984375
▁it 0.6806640625
▁not 3.66796875
▁only 0.001148223876953125
▁increases 5.57421875
▁card 3.830078125
i 0.03485107421875
ov 0.0011119842529296875
asc 4.875659942626953e-05
ular 7.3909759521484375e-06
▁ris 5.45703125
ks 1.9550323486328125e-05
▁but 0.353759765625
▁also 0.44384765625
▁height 6.69140625
ens 0.0153045654296875
▁the 0.338134765625
▁sus 6.72265625
cept 0.0001207590103149414
ibility 0.0007243156433105469
▁to 0.491943359375
▁breast 0.71240234375
▁cancer 0.00923919677734375
. 0.29345703125
<0x0A> 0.221923828125
b 0.08685302734375
) 0.0005388259887695312
▁Support 4.5234375
ive 1.6162109375
▁measures 3.919921875
: 0.043426513671875
▁Of 5.6015625
fer 0.0008091926574707031
ing 0.0250244140625
▁sm 2.591796875
oking 1.78125
▁c 0.123046875
ess 0.0001125335693359375
ation 0.00010824203491210938
▁resources 2.94921875
, 1.2265625
▁coun 3.740234375
sel 0.0458984375
ing 0.003086090087890625
, 0.290283203125
▁or 2.7265625
▁nic 3.634765625
ot 5.793571472167969e-05
ine 0.0023956298828125
▁replacement 0.4599609375
▁ther 0.09051513671875
ap 0.95458984375
ies 0.00011169910430908203
▁can 1.06640625
▁aid 3.583984375
▁women 3.6875
▁in 0.5439453125
▁over 3.7890625
coming 0.0007700920104980469
▁this 2.134765625
▁add 2.76171875
iction 0.08953857421875
. 0.556640625
<0x0A> 0.037994384765625
Con 3.208984375
clusion 0.360107421875
: 0.30322265625
<0x0A> 7.25390625
In 2.318359375
▁man 7.8359375
aging 0.0002677440643310547
▁the 0.92236328125
▁sympt 0.98779296875
oms 0.0069427490234375
▁of 0.436767578125
▁prem 0.10546875
ature 0.0013427734375
▁men 0.006961822509765625
op 0.00022101402282714844
ause 0.00183868408203125
▁in 2.658203125
▁middle 0.471435546875
- 0.0185394287109375
aged 0.01727294921875
▁women 0.01053619384765625
▁with 3.8515625
▁ob 0.748046875
es 0.00247955322265625
ity 1.2874603271484375e-05
▁and 1.2080078125
▁a 0.53857421875
▁pre 0.162841796875
dis 0.005680084228515625
position 0.0019855499267578125
▁to 0.098876953125
▁breast 0.032745361328125
▁cancer 0.0012559890747070312
, 0.0228424072265625
▁both 4.171875
▁Met 0.50634765625
op 0.004894256591796875
rol 0.00016200542449951172
ol 1.2040138244628906e-05
▁and 0.0139312744140625
▁Nor 0.007160186767578125
vas 0.0003075599670410156
c 0.0001589059829711914
▁present 4.34765625
▁potential 3.54296875
▁ris 2.1171875
ks 5.340576171875e-05
▁and 0.0975341796875
▁benefits 0.050537109375
. 0.40576171875
▁A 4.1328125
▁personal 4.3828125
ized 0.0265960693359375
▁approach 2.37109375
▁must 2.546875
▁be 0.08837890625
▁adopted 3.619140625
, 1.693359375
▁considering 0.94384765625
▁individual 3.099609375
▁patient 3.443359375
▁factors 1.189453125
▁and 1.97265625
▁prefer 2.607421875
ences 0.0013484954833984375
. 0.6513671875
▁Moreover 5.8046875
, 0.0005536079406738281
▁incorpor 5.0625
ating 0.0214080810546875
▁a 2.181640625
▁health 1.326171875
y 0.02099609375
▁di 0.202880859375
et 0.00013506412506103516
▁and 0.0850830078125
▁prom 5.8828125
oting 0.004795074462890625
▁sm 0.4482421875
oking 0.000545501708984375
▁c 0.0109100341796875
ess 1.4185905456542969e-05
ation 0.00011217594146728516
▁into 3.529296875
▁the 0.31201171875
▁treatment 0.0892333984375
▁plan 0.040985107421875
▁will 2.97265625
▁enh 2.931640625
ance 4.756450653076172e-05
▁the 1.1123046875
▁overall 1.6123046875
▁effect 2.33984375
iveness 0.00858306884765625
▁of 0.24658203125
▁medic 4.06640625
ation 0.16796875
▁and 1.1142578125
▁potentially 3.099609375
▁reduce 0.5556640625
▁the 0.453857421875
▁risk 0.268310546875
▁factors 6.30859375
▁associated 0.58837890625
▁with 0.0018205642700195312
▁ob 4.0078125
es 0.00301361083984375
ity 1.6927719116210938e-05
, 3.443359375
▁card 3.486328125
i 0.0058746337890625
ov 0.0014133453369140625
asc 2.8252601623535156e-05
ular 1.7642974853515625e-05
▁issues 2.537109375
, 0.0072174072265625
▁and 0.06451416015625
▁breast 0.73486328125
▁cancer 0.0038127899169921875
. 0.2568359375
